Bezuclastinib Tablets (Formulation B)

Drug identity checked against registry records

Also recorded as CGT9486; PLX9486

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic MastocytosisNCT05186753COGTPhase 2Active not recruiting2025-05-22Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.